BACTEC PEDS PLUS/F 442194

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 05 report with the FDA on 2005-06-23 for BACTEC PEDS PLUS/F 442194 manufactured by Bd Caribe, Ltd..

Event Text Entries

[21470042] Further investigation into this event indicates that the blood specimen was likely drawn during the morning and the inoculated blood culture bottle was not placed into the bactec 9050 instrument until 1:00pm in the afternoon. In this instance, there must have been significant growth of the k. Pneumoniae from the time the blood was inoculated into the vial and its receipt into the laboratory, since there were enough organisms for the direct gram stain to be positive, as well as enough for a direct id/ast procedure (both of which would require approximately 100,000 orgs/ml). The most likely reason that the instrument failed to detect this organism would be the delayed entry of the vial into the instrument, which gave the organism an opportunity for significant growth, prior to entry into the instrument. Patients with signs of suspected sepsis are empirically treated with broad-spectrum antibiotics. The recovery of the etiologic agent from a blood culture, as well as the subsequent identification and antimicrobial susceptibility results, are important in the management of the patient, in order to ensure that appropriate antibiotics are continued to be given to the patient. As noted in b. 5. The patient recovered from the sepsis event. Retention samples of the same lot of culture media were evaluated using the organism involved in this event with acceptable recovery. The batch history record for this lot was reviewed and found acceptable. Unable to confirm this event.
Patient Sequence No: 1, Text Type: N, H10


[21592376] A septic premature infant had approximately 1 ml of blood inoculated into a bactec peds plus culture medium bottle. The bottle was subsequently loaded into a bactec 9050 instrument for blood culturing. The inoculated bottle remained instrument negative for 5 days of incubation. Direct microscopic examination and direct culture/susceptibility testing was performed from the specimen at the time the blood was inoculated into the blood culture bottle. An organism was isolated from the direct culture, klebsiella pneumoniae. The instrument negative blood culture bottle from this patient was examined microscopically and cultured. An organism was isolated from the instrument negative bottle, klebsiella pneumoniae. The premature infant recovered from the sepsis event.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1119779-2005-00001
MDR Report Key744593
Report Source05
Date Received2005-06-23
Date of Report2005-06-21
Date of Event2005-05-23
Date Mfgr Received2005-05-23
Date Added to Maude2006-08-08
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location0
Manufacturer ContactJOHN GERLICH
Manufacturer Street7 LOVETON CIRCLE
Manufacturer CitySPARKS MD 21152
Manufacturer CountryUS
Manufacturer Postal21152
Manufacturer Phone4103164464
Manufacturer G1*
Manufacturer Street*
Manufacturer City*
Manufacturer Country*
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameBACTEC PEDS PLUS/F
Generic NameBLOOD CULTURE MEDIUM
Product CodeJTA
Date Received2005-06-23
Model NumberNA
Catalog Number442194
Lot Number4324535
ID NumberNA
Device Expiration Date2005-09-30
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrR
Implant FlagN
Date Removed*
Device Sequence No1
Device Event Key732400
ManufacturerBD CARIBE, LTD.
Manufacturer Address* CAYEY PR * US
Baseline Brand NameBACTEC PEDS PLUS/F CULTURE MEDIUM
Baseline Generic NameBLOOD CULTURE MEDIUM
Baseline Model NoNA
Baseline Catalog No442194
Baseline IDLOT# 4324535
Baseline Shelf Life Contained*
Baseline Shelf Life [Months]9
Baseline PMA FlagN
Baseline 510K PMNY
Premarket NotificationK954927
Baseline PreamendmentN
Baseline TransitionalN
510k ExemptN


Patients

Patient NumberTreatmentOutcomeDate
10 2005-06-23

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.